Revelo: AI For Retina
25% of your patients have a retinal disease.
The Revelo AI can help you diagnose all of them from a retinal
photo: non-invasively, accurately and in a minute.
Schedule A Demo
Zero Setup Fees. Zero Capital Expense. Start adding value to your practice now.
Enable early diagnosis
Better health outcomes. Simpler care delivery. Less expensive management.
Refer out only when you need to
You can screen patients yourself - without referring every case to a specialist.
AI = Additional Income
Augment your revenue from the first day. Improve HEDIS Scores. Pay only for usage.
Deep Learning Powered
Cutting-edge technology that helps diagnose diseases like macular degeneration, diabetic retinopathy, glaucoma, RVOs and more.
Hundreds of Diseases
90% sensitivity and 88% specificity with any fundus camera. Diagnoses 15 clinical signs with differentials for 100s of diseases.
How It Works
- Take Retinal Photo: We provide a simple-to-use fundus camera (no extra cost). If you already have one, we will integrate with it. Training takes a couple of hours, and no dilating eye drops are needed for the patient.
- AI Analysis: The images are automatically uploaded to a secure cloud, and analysed by the Revelo AI.
- Reporting: Reports are available immediately. You can access them anywhere - on your phone, on your laptop or send it out in an email or WhatsApp link.
Full Stack Service
A Complete Turnkey Solution
We set up the fundus camera, coordinate with IT & trainings. You can just focus on the patient.
24x7x365 Support. Free.
We know how important quality care is. We work with the best: individual practices, hospital systems, state health systems and pharma. We are always available to support you - operationally, and clinically.
Start a Trial
Diagnose your patients faster than ever before. Start a 14 day trial in your clinic, completely free.
Burden of Disease
Retinal diseases are some of the most complex to diagnose and expensive to manage. They are strongly correlated with age and systemic diseases like diabetes and cardiovascular diseases.
Burden of Disease
We are sitting on a ticking time bomb of explosion of retinal diseases and blindness.
A billion people are at risk.
Early changes are imperceptible.
Almost all chronic retinal diseases are completely asymptomatic in the early stages - allowing the disease to progress to an advanced stage without diagnosis.
Retinal diseases cause irreversible damage.
Chronic retinal diseases cannot be reversed, and even with the best therapies and complex surgeries, the chances of getting back perfect vision are close to zero. Early diagnosis and treatment is the only way to protect vision.
Age-Related Macular Degeneration
All AMD starts out as a benign finding (dry AMD), but a fraction of them turn neovascular (wet AMD) - this is the largest cause of vision loss in the aged population. Revelo helps you screen for the earliest signs of AMD using AI.
Diabetic retinopathy is a complication of diabetes that affects up to 80% of all diabetics. It is the leading cause of blindness for people between 20 to 64 years of age. 90% of new cases can be reduced by early diagnosis and treatment - and Revelo allows you to do that.
Glaucoma has been called the "silent thief": a disease that robs blindness in a way that the patient won't know it until it's too late. Revelo allows the easiest way of screening for glaucoma at the point of care.
Start a Trial
There is no greater pleasure than being able to prevent disease. Start finding hidden cases now.
The current process is cumbersome, expensive and time-consuming.
Patients do not like being shifted around from office to office to get diagnosed or rule out a disease they often don't have symptoms for, and do not understand in detail.
The net effect of the current convoluted process is that patients end up not seeking the care and consultation they need. Diseases go undiagnosed till it's too late, and preventable illnesses progress to blindness.
At Risk Group Identification
Clinically select patients who might need screening based on symptoms or risk factors. Most patients unfortunately are asymptomatic.
Patients are often unaware about retinal diseases, and so they need to be convinced about spending money on screening for them.
Finding The Right Specialist
The patient needs to search for a specialist near them who fits their budget, insurance and other criteria.
Waiting For An Appointment
Finding the specialist is only one part of the job: appointment wait times can be as high as months.
Finally, Specialist Consultation
Naturally, the adherence rate for these consultations are low: they can be as low as single digit percentages in some cases.
Back To You
Only a few patients will go through this cycle annually. Even when they do, you get their reports with a delay of months.
Powered By Revelo
AI Supercharged Workflow
What can take multiple visits, days off work and months on end can now be done in minutes, in your office.
Take A Photo
Take a retinal photo of the patient. No eye drops necessary. Training to take a good photo takes a couple of hours, and any member of staff can do it.
Revelo: Deep Learning
The images are automatically analysed by the secure, cloud-based Revelo AI platform. Analysis takes less than a minute.
Refer Only When Necessary
Refer patients who have findings in the Revelo report. Manage the rest in your clinic and re-screen as frequently as needed.
Reduce the time to diagnosis from potentially months to a few minutes. Set a bar in excellence that patients will appreciate.
Help patients avoid expensive consultations to rule out disease, and help them avoid expensive therapies by enabling early diagnosis.
Make It Easy
Preventive health shouldn't make people jump through hoops. Give patients what they need at the right time in one place - your office.
It's time to move to a better, faster and cheaper model. Chart the path ahead for your practice.
Revelo: AI For Retina
Revelo deployments are bespoke, turnkey solutions.
We cover everything: from the hardware used (retinal fundus camera) to trainings and IT integrations.
If you have a fundus camera, we will integrate with it. Otherwise, we will provide one at no extra cost. We use cameras that don't require eye dilation for imaging.
The fundus camera connects to a laptop or a tab. We will provide these and help set it up. We will set up report printing as well as WhatsApp accounts to send reports online.
Revelo is a web-based platform, accessible from anywhere -- and easy to use. We will train your personnel on using it as well as imaging patients. This takes a few hours and some practice.
Custom EMR Integrations? Custom Workflow Solutions? We're happy to discuss.
Where do I use Revelo?
Based on your practice, we can guide you about the best place in your office to set up Revelo. Often, it is done as part of vitals and rooming.
What's the technology behind Revelo?
The core algorithm behind Revelo is a deep neural network. These are artificial intelligence algorithms that are trained on large amounts of data (in this case, fundus photographs graded by expert clinicians). Once trained, the algorithms learn to emulate the expert clinicians and can start producing outputs on its own. The algorithm behind Revelo has been trained on more than a million images, with inputs from over 20 trained retina specialists.
Can you integrate with my EMR?
Yes. For major EMRs, we have pre-built integrations. For others, we will work with your team to create a custom solution.
What clinical signs does Revelo detect?
Revelo is designed to improve on its own and detect an ever-growing list of abnormalities.
Right now, it detects glaucomatous discs, preretinal haemorrhages, dot and blot haemorrhages, flame-shaped haemorrhages, optic disc edema, hard exudates, vascular sheathing, vitreous haze, arteriovenous nicking, vascular tortuosity, retinal neovascularisation, macular edema, cotton wool spots, drusens and sclerosed vessels.
We add more features to this list every few months, after extensive clinical trials.
What diseases are covered by the signs detected by Revelo?
The combination of signs detected by Revelo can lead to the diagnosis of hundreds of diseases.
The most common diseases include diabetic retinopathy or DR, a complication of diabetes; age-related macular degeneration or AMD, one of the leading causes of irreversible blindness associated with ageing and glaucoma, a disease where the optic nerve is damaged.
Other diseases include hypertensive retinopathy, HIV retinopathy, retinal vascular occlusions, inflammations of various etiologies in the retina, macular edema caused by different factors, toxic reactions to various agents and more.
Can I customise the Revelo report?
Of course! We will white label the report with your clinic's branding. We put your clinic's name, address, office phone numbers and logo on the report, as well as the name of the ordering clinician.
We also try to make our report helpful to the patient by providing information about signs of disease that are detected -- and we are continuously on the look out for collaborators who we can work with to improve messaging that motivates patient compliance.
What's the regulatory status of Revelo?
Revelo is available for full commercial use outside US and EU. It is available for investigational use in US, and regulatory approvals are in process.
How do you use patient's data?
How is security maintained?
All data is encrypted at rest and in transit using industry-standard best practices. We are in the process of obtaining SOC-2 Compliance, and all our staff members are regularly trained on security practices including HIPAA and GDPR.
How can we work together?
We are always on the lookout for partners and we love working with great people. Please reach out!
Please reach out to us over email at firstname.lastname@example.org -- or simply schedule a meeting right now!